Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AFAMNYSE:DGXNYSE:DVANYSE:LH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAFAMAlmost Family$56.00$0.00$40.15▼$66.15N/AN/A147,403 shsN/ADGXQuest Diagnostics$179.93+0.1%$174.94$135.47▼$182.38$20.06B0.49993,018 shs707,321 shsDVADaVita$140.90+3.3%$139.45$131.76▼$179.60$10.29B1.11803,931 shs726,202 shsLHLabcorp$262.69+0.6%$245.76$198.96▼$264.03$21.85B0.81635,447 shs664,003 shs13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAFAMAlmost Family0.00%0.00%0.00%0.00%0.00%DGXQuest Diagnostics+0.11%+0.55%+5.02%+7.96%+28.31%DVADaVita+3.34%+3.10%+1.88%-6.87%-2.13%LHLabcorp+0.64%+1.28%+8.24%+12.67%+26.29%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAFAMAlmost FamilyN/AN/AN/AN/AN/AN/AN/AN/ADGXQuest Diagnostics4.9071 of 5 stars2.34.04.24.72.92.52.5DVADaVita4.4587 of 5 stars2.01.00.04.52.81.74.4LHLabcorp4.4661 of 5 stars2.43.02.54.22.82.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAFAMAlmost Family 0.00N/AN/AN/ADGXQuest Diagnostics 2.69Moderate Buy$185.733.22% UpsideDVADaVita 2.00Hold$164.5016.75% UpsideLHLabcorp 2.86Moderate Buy$274.004.31% UpsideCurrent Analyst Ratings BreakdownLatest AFAM, DGX, LH, and DVA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/11/2025LHLabcorpMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$270.00 ➝ $283.005/19/2025DVADaVitaTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$170.00 ➝ $164.005/12/2025LHLabcorpTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$274.00 ➝ $290.005/6/2025LHLabcorpPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$260.00 ➝ $280.005/6/2025DGXQuest DiagnosticsJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$180.00 ➝ $190.004/30/2025LHLabcorpBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$240.00 ➝ $250.004/30/2025LHLabcorpRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$253.00 ➝ $267.004/28/2025DGXQuest DiagnosticsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$180.00 ➝ $200.004/23/2025DGXQuest DiagnosticsTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetHold ➝ Hold$182.00 ➝ $190.004/23/2025DGXQuest DiagnosticsEvercore ISISubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetIn-Line ➝ In-Line$175.00 ➝ $180.004/23/2025DGXQuest DiagnosticsBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$175.00 ➝ $185.00(Data available from 6/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAFAMAlmost FamilyN/AN/AN/AN/AN/AN/ADGXQuest Diagnostics$9.87B2.03$13.52 per share13.31$61.38 per share2.93DVADaVita$12.82B0.83$19.79 per share7.12$4.83 per share29.17LHLabcorp$13.01B1.69$22.55 per share11.65$96.27 per share2.73Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAFAMAlmost FamilyN/AN/A0.00∞N/AN/AN/AN/AN/ADGXQuest Diagnostics$871M$7.9122.7517.152.518.81%15.11%6.65%7/22/2025 (Estimated)DVADaVita$936.34M$10.0913.9611.090.946.63%176.11%4.66%8/5/2025 (Estimated)LHLabcorp$746M$8.6530.3714.981.655.55%15.27%6.97%7/30/2025 (Estimated)Latest AFAM, DGX, LH, and DVA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/22/2025Q2 2025DGXQuest Diagnostics$2.56N/AN/AN/A$2.73 billionN/A5/12/2025Q1 2025DVADaVita$1.75$2.00+$0.25$2.00$3.22 billion$3.22 billion4/29/2025Q1 2025LHLabcorp$3.73$3.84+$0.11$2.52$3.41 billion$3.35 billion4/22/2025Q1 2025DGXQuest Diagnostics$2.15$2.21+$0.06$1.94$2.63 billion$2.65 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAFAMAlmost FamilyN/AN/AN/AN/AN/ADGXQuest Diagnostics$3.201.78%N/A40.46%14 YearsDVADaVitaN/AN/AN/AN/AN/ALHLabcorp$2.881.10%N/A33.29%N/ALatest AFAM, DGX, LH, and DVA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/14/2025DGXQuest Diagnosticsquarterly$0.801.86%7/7/20257/7/20257/21/20254/10/2025LHLabcorpquarterly$0.721.25%5/29/20256/11/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAFAMAlmost FamilyN/AN/AN/ADGXQuest Diagnostics0.841.441.31DVADaVita23.181.251.20LHLabcorp0.681.841.60Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAFAMAlmost Family84.64%DGXQuest Diagnostics88.06%DVADaVita90.12%LHLabcorp95.94%Insider OwnershipCompanyInsider OwnershipAFAMAlmost Family13.10%DGXQuest Diagnostics8.16%DVADaVita2.00%LHLabcorp0.84%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAFAMAlmost FamilyN/AN/AN/AOptionableDGXQuest Diagnostics56,000111.64 million102.53 millionOptionableDVADaVita76,00075.50 million73.99 millionOptionableLHLabcorp70,00083.70 million83.00 millionOptionableAFAM, DGX, LH, and DVA HeadlinesRecent News About These CompaniesKentucky Retirement Systems Insurance Trust Fund Makes New $569,000 Investment in Labcorp Holdings Inc. (NYSE:LH)June 25 at 3:52 AM | marketbeat.comGHP Investment Advisors Inc. Increases Position in Labcorp Holdings Inc. (NYSE:LH)June 24 at 5:20 AM | marketbeat.comEnvestnet Portfolio Solutions Inc. Lowers Holdings in Labcorp Holdings Inc. (NYSE:LH)June 24 at 3:44 AM | marketbeat.comWealth Enhancement Advisory Services LLC Has $8.42 Million Stock Holdings in Labcorp Holdings Inc. (NYSE:LH)June 24 at 3:24 AM | marketbeat.comLabcorp Holdings Inc.'s (NYSE:LH) Intrinsic Value Is Potentially 59% Above Its Share PriceJune 23 at 4:10 PM | uk.finance.yahoo.com5 Insightful Analyst Questions From Labcorp’s Q1 Earnings CallJune 23 at 11:09 AM | msn.comMarietta Wealth Management LLC Purchases 7,304 Shares of Labcorp Holdings Inc. (NYSE:LH)June 21, 2025 | marketbeat.comLabcorp Unveils Whole Health Solutions For Functional And Integrative Medicine ProvidersJune 20, 2025 | nasdaq.comIs Labcorp Holdings Stock Outperforming the Dow?June 20, 2025 | msn.comLabcorp Holdings Inc LHJune 19, 2025 | morningstar.com4,201 Shares in Labcorp Holdings Inc. (NYSE:LH) Acquired by Friedenthal FinancialJune 19, 2025 | marketbeat.comLabcorp Launches Labcorp Whole Health Solutions to Support Holistic CareJune 18, 2025 | finance.yahoo.comLabcorp Stock Climbs 25.6% This Year: What's Driving the Surge?June 18, 2025 | zacks.comPKO Investment Management Joint Stock Co Invests $233,000 in Labcorp Holdings Inc. (NYSE:LH)June 18, 2025 | marketbeat.comLabcorp Holdings Inc. stock underperforms Monday when compared to competitors despite daily gainsJune 18, 2025 | marketwatch.comLabcorp Holdings Inc. stock outperforms competitors despite losses on the dayJune 18, 2025 | marketwatch.comBirch Hill Investment Advisors LLC Has $33.43 Million Stock Position in Laboratory Co. of America Holdings (NYSE:LH)June 17, 2025 | marketbeat.comMn Services Vermogensbeheer B.V. Sells 2,400 Shares of Laboratory Co. of America Holdings (NYSE:LH)June 17, 2025 | marketbeat.comFarther Finance Advisors LLC Has $430,000 Stock Holdings in Laboratory Co. of America Holdings (NYSE:LH)June 17, 2025 | marketbeat.comLaboratory Co. of America (NYSE:LH) Sets New 52-Week High - Time to Buy?June 16, 2025 | marketbeat.comAzzad Asset Management Inc. ADV Makes New Investment in Laboratory Co. of America Holdings (NYSE:LH)June 16, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeIntel's Turnaround Strategy Shifts From Planning to Attack ModeBy Jeffrey Neal Johnson | June 20, 2025View Intel's Turnaround Strategy Shifts From Planning to Attack ModeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s WatchingAFAM, DGX, LH, and DVA Company DescriptionsAlmost Family NASDAQ:AFAMAlmost Family, Inc. is a provider of home healthcare services. The Company has two divisions: Home Health and Healthcare Innovations (HCI). The Home Health division consists of two segments: Visiting Nurse Services (VN or Visiting Nurse) and Personal Care Services (PC or Personal Care). The VN segment provides a range of Medicare-certified home health nursing services to patients in need of recuperative care, following a period of hospitalization or care in another type of inpatient facility. The PC segment provides services in patients' homes primarily on an as-needed, hourly basis. These services include personal care, medication management, meal preparation, caregiver respite and homemaking. The HCI segment includes its developmental activity outside of the home health business platform. HCI activities include technology, information, population health management, risk-sharing, enhanced patient engagement and informed clinical decision making.Quest Diagnostics NYSE:DGX$179.93 +0.21 (+0.12%) Closing price 06/24/2025 03:59 PM EasternExtended Trading$171.94 -7.99 (-4.44%) As of 06/24/2025 07:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.DaVita NYSE:DVA$140.90 +4.56 (+3.35%) Closing price 06/24/2025 03:59 PM EasternExtended Trading$140.90 0.00 (0.00%) As of 06/24/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.Labcorp NYSE:LH$262.69 +1.65 (+0.63%) Closing price 06/24/2025 03:59 PM EasternExtended Trading$262.61 -0.08 (-0.03%) As of 06/24/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Hot Trades for Insiders, But Are They Good Buys for Investors? Why Qualcomm’s Latest Price Target Can't Be Ignored Texas Instruments Stock: Congress Likes It, Should You Too? Geospace Stock Skyrockets After Major Petrobras Contract Analyst Sees Meta Hitting $800: What May Lead Shares to New Highs CrowdStrike Eyes Breakout as Cyber Threats Boost Demand Reddit Stock Ignites: Surge in Call Options Signals Big Bet Microsoft Stock Holds Steady as AI Drives Workforce Shift Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
